Lv51
1040 积分 2024-12-09 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
9天前
已完结
Roads and detours for CAR T cell therapy in autoimmune diseases
9天前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
9天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
9天前
已完结
Daratumumab monotherapy for refractory lupus nephritis
1个月前
已完结
Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia
1个月前
已完结
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
1个月前
已完结
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
1个月前
已完结
ABBV-303 Is an NK-cell Engager Specific for c-Met–Expressing Tumors
2个月前
已完结
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
2个月前
已完结
皖公网安备34019202002308
